Interpace Biosciences Inc
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.5M | $1.5M | $3.5M | $4.8M | $2.7M | $2.8M | $2.3M | $6.1M |
| Accounts Receivable | $5.6M | $8.5M | $5.1M | $5.0M | $4.7M | $8.0M | $10.3M | $9.5M |
| Inventory | $1.1M | $1.2M | $1.2M | $1.2M | $825.0K | $2.1M | $1.8M | — |
| Total Current Assets | $9.9M | $11.8M | $10.4M | $12.2M | $12.2M | $14.1M | $16.5M | $17.7M |
| Property, Plant & Equipment | $1.4M | $1.4M | $790.0K | $480.0K | $317.0K | $7.3M | $6.8M | $837.0K |
| Goodwill | — | — | — | — | $8.4M | $8.4M | $8.4M | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | $861.0K | $2.1M | $11.4M | $15.8M | $12.5M |
| Total Assets | $33.8M | $14.8M | $13.1M | $16.0M | $38.4M | $45.7M | $51.5M | $31.1M |
| Liabilities | ||||||||
| Accounts Payable | $983.0K | $1.7M | $1.5M | $1.1M | $1.4M | $4.5M | $4.7M | $1.1M |
| Total Current Liabilities | $5.1M | $10.6M | $11.4M | $14.3M | $15.7M | $18.2M | $17.3M | $8.7M |
| Long-Term Debt | — | — | — | $1.8M | $520.0K | $3.7M | $2.7M | — |
| Total Liabilities | $11.5M | $17.0M | $22.1M | $32.5M | $34.3M | $28.2M | $29.8M | $15.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-210.8M | $-235.4M | $-242.1M | $-249.0M | $-227.1M | $-212.1M | $-185.7M | $-159.0M |
| Total Stockholders' Equity | $22.4M | $-2.2M | $-55.5M | $-58.1M | $-42.4M | $-29.1M | $-4.5M | $15.4M |